Clinical outcomes of nalidixic acid, ceftriaxone, and multidrug-resistant nontyphoidal salmonella infections compared with pansusceptible infections in foodnet sites, 2006-2008

Foodborne Pathogens and Disease

Volumn 11, Issue 5, 2014, Pages 335-341

  Krueger, Amy L ^a   Greene, Sharon A ^a   Barzilay, Ezra J ^a   Henao, Olga ^a   Vugia, Duc ^b   Hanna, Samir ^c   Meyer, Stephanie ^d   Smith, Kirk ^d   Pecic, Gary ^a,e   Hoefer, Dina ^f   Griffin, Patricia M ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b CALIFORNIA DEPARTMENT OF PUBLIC HEALTH   (United States)

^c TENNESSEE DEPARTMENT OF HEALTH   (United States)

^d MINNESOTA DEPARTMENT OF HEALTH   (United States)

^e International Health Resource Consulting   (United States)

^f NEW YORK STATE DEPARTMENT OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; CEFOXITIN; CEFTIOFUR; CEFTRIAXONE; CHLORAMPHENICOL; CIPROFLOXACIN; COTRIMOXAZOLE; GENTAMICIN; KANAMYCIN; NALIDIXIC ACID; STREPTOMYCIN; SULFAFURAZOLE; TETRACYCLINE; ANTIINFECTIVE AGENT;

ADOLESCENT; ADULT; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; BLOODSTREAM INFECTION; BROTH DILUTION; CHILD; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE PREDISPOSITION; DRUG EFFICACY; DRUG SAFETY; FEMALE; GASTROINTESTINAL INFECTION; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MINIMUM INHIBITORY CONCENTRATION; MULTICENTER STUDY; MULTIDRUG RESISTANCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SALMONELLA; SALMONELLA PARATYPHI B; SALMONELLA PARATYPHI C; SALMONELLA TYPHIMURIUM; SALMONELLOSIS; SEMI STRUCTURED INTERVIEW; SEROTYPE; TREATMENT OUTCOME; ANALYSIS; CLINICAL TRIAL; COMPARATIVE STUDY; DRUG EFFECTS; FOOD CONTAMINATION; FOOD CONTROL; ISOLATION AND PURIFICATION; MICROBIAL SENSITIVITY TEST; MIDDLE AGED; PRESCHOOL CHILD; SALMONELLA FOOD POISONING; YOUNG ADULT;

ADOLESCENT; ADULT; AMPICILLIN; ANTI-BACTERIAL AGENTS; CEFTRIAXONE; CHILD; CHILD, PRESCHOOL; CHLORAMPHENICOL; DRUG RESISTANCE, MULTIPLE, BACTERIAL; FEMALE; FOOD CONTAMINATION; FOOD MICROBIOLOGY; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; NALIDIXIC ACID; PROSPECTIVE STUDIES; SALMONELLA; SALMONELLA FOOD POISONING; STREPTOMYCIN; SULFISOXAZOLE; TETRACYCLINE; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84899821997     PISSN: 15353141     EISSN: 15567125     Source Type: Journal    
DOI: 10.1089/fpd.2013.1642     Document Type: Article

References (27)

1. Besser TE, Goldoft M, Pritchett LC, et al. Multiresistant Salmonella Typhimurium DT104 infections of humans and domestic animals in the Pacific Northwest of the United States. Epidemiol Infect 2000;124:193-200
2. [CDC] Centers for Disease Control and Prevention. Foodbome Diseases Active Surveillance Network (FoodNet): FoodNet Surveillance Report for 2008 (Final Report) Volume. Atlanta, GA: U.S. Department of Health and Human Services, CDC, 2010. Available at: Http://www.cdc.gov/foodnet/AR2008-508- Compliant-v3-FINAL.pdf, accessed July 22, 2011
3. CLSI] Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing; Twenty-Third Informational Supplement. CLSI Document M100-S23. Volume 33. Wayne, PA: CLSI, 2013
4. Cody SH, Abbott SL, Marfin AA, et al. Two outbreaks of multidrug-resistant Salmonella serotype Typhimurium DT104 infections linked to raw-milk cheese in Northern California. JAMA 1999;281:1805-1810
5. Crump JA, Medalla FM, Joyce KW, et al. Antimicrobial resistance among invasive nontyphoidal Salmonella enterica isolates in the United States: National Antimicrobial Resistance Monitoring System, 1996 to 2007. Antimicrob Agents Chemother 2011;55:1148-1154
6. Davis MA, Hancock DD, Besser TE, et al. Changes in antimicrobial resistance among Salmonella enterica serovar Typhimurium isolates from humans and cattle in the Northwestern United States, 1982-1997. Emerg Infect Dis 1999; 5:802-806
7. Dechet AM, Scallan E, Gensheimer K, et al. Outbreak of multidrug-resistant Salmonella enterica serotype Typhimurium definitive type 104 infection linked to commercial ground beef, northeastern United States, 2003-2004. Clin Infect Dis 2006; 42:747-752
8. Devasia R, Varma J, Whichard J, et al. Antimicrobial use and outcomes in patients with multidrug-resistant and pansusceptible Salmonella Newport infections, 2002-2003. Microbial Drug Resistance 2005;11:371-377
9. Glenn LM, Lindsey RL, Frank JF, et al. Analysis of antimicrobial resistance genes detected in multidrug-resistant Salmonella enterica serovar Typhimurium isolated from food animals. Microb Drug Resist 2011;17:407-418
10. Glynn MK, Bopp C, Dewitt W, Dabney P, Mokhtar M, Angulo F.J. Emergence of multidrug-resistant Salmonella enterica serotype Typhimurium DT104 infections in the United States. N Engl J Med 1998;338:1333-1338
11. Guerrant RL, Van Gilder T, Steiner TS, et al. Practice guidelines for the management of infectious diarrhea. Clin Infect Dis 2001;32:331-351
12. Helms M, Simonsen J, Molbak K. Quinolone resistance is associated with increased risk of invasive illness or death during infection with Salmonella serotype Typhimurium. J Infect Dis 2004;190:1652-1654
13. Helms M, Vastrup P, Gerner-Smidt P, Molbak K. Excess mortality associated with antimicrobial drug-resistant Salmonella Typhimurium. Emerg Infect Dis 2002;8:490-495
14. Holmberg SD, Wells JG, Cohen ML. Animal-To-man transmission of antimicrobial-resistant Salmonella: Investigations of U.S. outbreaks, 1971-1983. Science 1984;225:833-835
15. Martin L, Fyfe M, Doré K, et al. Increased burden of illness associated with antimicrobial-resistant Salmonella enterica serotype Typhimurium infections. J Infect Dis 2004;189:377-384
16. Molbak K. Human health consequences of antimicrobial drugresistant Salmonella and other foodborne pathogens. Clin Infect Dis 2005;41:1613-1620
17. Olsen S, Ying M, Davis M, et al. Multidrug-resistant Salmonella Typhimurium infection from milk contaminated after pasteurization. Emerg Infect Dis 2004;10:932-935
18. Poppe C, Smart N, Khakhria R, Johnson W, Spika J, Prescott J. Salmonella typhimurium DT104: A virulent and drug-resistant pathogen. Can Vet J 1998;39:559-565
19. Ribot E, Wierzba R, Angulo F, Barrett T. Salmonella enterica serotype Typhimurium DT104 isolated from humans, United States, 1985, 1990, and 1995.Emerg Infect Dis 2002;8:387-391
20. Scallan E. Activities, achievements, and lessons learned during the first 10 years of the Foodborne Diseases Active Surveillance Network: 1996-2005. Clin Infect Dis 2007;44:718-725
21. Scallan E, Hoekstra RM, Angulo F, et al. Foodborne illness acquired in the United States-Major pathogens. Emerg Infect Dis 2011;17:7-15
22. Solghan SM, Dumas NB, Root TP, et al. Multidrug-resistant nontyphoidal Salmonella in New York state's Foodborne Diseases Active Surveillance Network counties. Foodborne Pathog Dis 2010;7:167-173
23. Threlfall EJ, Ward LR, Rowe B. Multiresistant Salmonella Typhimurium DT 104 and Salmonella bacteraemia. Lancet 1998;352:287-288
24. Varma JK, Greene K, Ovitt J, Barrett T, Medalla F, Angulo F. Hospitalization and antimicrobial resistance in Salmonella outbreaks, 1984-2002. Emerg Infect Dis 2005a;11:943-946
25. Varma JK, Molbak K, Barrett TJ, et al. Antimicrobial-resistant nontyphoidal Salmonella is associated with excess bloodstream infections and hospitalizations. J Infect Dis 2005b; 191:554-561
26. Villar RG, Macek MD, Simons S, et al. Investigation of multidrug-resistant Salmonella serotype Typhimurium DT104infections linked to raw-milk cheese in Washington State. JAMA 1999;281:1811-1816.
27. Wall PG, Morgan D, Lamden K, et al. A case control study of infection with an epidemic strain of multiresistant Salmonella Typhimurium DT104 in England and Wales. CDR Rev 1994; 4:R130-R135